European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
A refined coadministration regime to mitigate immunological clearance of biomedical nanoparticles.
Kathrin Schorr, Johannes Konrad, Jan Birringer, Carsten Damm, Miriam Breunig, Achim Goepferich
Published: 202610.1016/j.ejpb.2026.114989
Abstract
Nanoparticles are frequently designed as carriers to mediate the active transport of their cargo to the site of action, thereby serving as effector particles. However, after their in vivo administration, they become quickly recognized by immune cells…
Preview only. Read the full abstract at the source